Clearance of amino acids by hemodialysis in argininosuccinate synthetase deficiency

Journal of Pediatrics

Volumn 144, Issue 4, 2004, Pages 536-540

  McBryde, Kevin D ^a   Kudelka, Timothy L ^b   Kershaw, David B ^b   Brophy, Patrick D ^b   Gardner, John J ^b   Smoyer, William E ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININOSUCCINATE SYNTHASE;

AMINO ACID METABOLISM; AMMONIA BLOOD LEVEL; ARTICLE; CASE REPORT; CITRULLINEMIA; DIALYSIS; HEMODIALYSIS; HUMAN; HYDRATION; HYPERAMMONEMIA; INBORN ERROR OF METABOLISM; KIDNEY CLEARANCE; NEWBORN; NITROGEN URINE LEVEL; PRIORITY JOURNAL; PROTEIN INTAKE; SUBSTITUTION THERAPY; UREA CYCLE;

EID: 1842502924     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2004.01.037     Document Type: Article

References (34)

1. Batshaw ML, Brusilow S, Waber L, Blom W, Brubakk AM, Burton BK, et al. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion. N Engl J Med 1982;306:1387-92.
2. Leonard JV. The early detection and management of inborn errors presenting acutely in the neonatal period. Eur J Pediatr 1985;143:253-7.
3. Leonard JV. Disorders of the urea cycle. In: Fernandes J, Saudubray JM, Van den Berghe G, editors. Inborn metabolic diseases: diagnosis and treatment. 3rd revised edition. Berlin: Springer; 2000. p. 214-22.
4. Urea Cycle Disorders Conference Group. Consensus statement from a conference for the management of patients with urea cycle disorders. J Pediatr 2001;138(Suppl 1):S1-5.
5. Mathias RS, Kostiner D, Packman S. Hyperammonemia in urea cycle disorders: role of the nephrologist. Am J Kidney Dis 2001;37:1069-80.
6. Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED. neurologic outcome in children with inborn errors of urea synthesis: outcome of ureacycle enzymopathies. N Engl J Med 1984;310:1500-5.
7. Summar M, Tuchman M. Proceedings of a consensus conference for the management of patients with urea cycle disorders. J Pediatr 2001;138(Suppl 1):S6-10.
8. Hoshide R, Soejima H, Ohta T, Niikawa N, Haraguchi Y, Matsuura T, et al. Assignment of the human carbamyl phosphate synthetase I gene (CPS1) to 2q35 by fluorescence in situ hybridization. Genomics 1995;28: 124-125.
9. Lindgren V, de Martinville B, Horwich AL, Rosenberg LE, Francke U. Human ornithine transcarbamylase locus mapped to band Xp21.1 near the Duchenne muscular dystrophy locus. Science 1984;226:698-700.
10. Northrup H, Lathrop M, Lu SY, Daiger SP, Beaudet AL, O'Brien WE. Multilocus linkage analysis with the human argininosuccinate synthetase gene. Genomics 1989;5:442-4.
11. Todd S, McGill JR, McCombs JL, Moore CM, Weider I, Naylor SL. cDNA sequence, interspecies comparison, and gene mapping analysis of argininosuccinate lyase. Genomics 1989;4:53-9.
12. Sparkes RS, Dizikes GJ, Klisak I, Grody WW, Mohandas T, Heinzmann C, et al. The gene for human liver arginase (ARG1) is assigned to chromosome band 6q23. Am J Hum Genet 1986;39:186-93.
13. Caldovic L, Morizonon H, Panglao MG, Gallegos R, Yu X, Shi D, et al. Cloning and expression of the human N-acetylglutamate synthase gene. Biochem Biophys Res Commun 2002;299:581-6.
14. Summar M. Current strategies for the management of neonatal urea cycle disorders. J Pediatr 2001;138(Suppl 1):S30-9.
15. Leonard JV. The nutritional management of urea cycle disorders. J Pediatr 2001;138(Suppl 1):S40-5.
16. McReynolds JW, Mantagos S, Brusilow S, Rosenberg LE. Treatment of ornithine transcarbamylase deficiency with nitrogen-free analogues of essential amino acids. J Pediatr 1978;93:421-7.
17. Batshaw ML, Brusilow SW. Treatment of hyperammonemic coma caused by inborn errors of urea synthesis. J Pediatr 1980;97:893-900.
18. Brusilow SW, Danney M, Waber LJ, Batshaw M, Burton B, Levitsky L, et al. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N Engl J Med 1984;310:1630-4.
19. Maestri NE, Hauser ER, Bartholomew D, Brusilow SW. Prospective treatment of urea cycle disorders. J Pediatr 1991;119:923-8.
20. Snyderman SE, Sansaricq C, Phansalkar SV, Schacht RG, Norton PM. The therapy of hyperammonemia due to ornithine transcarbamylase deficiency in a male neonate. Pediatrics 1975;56:65-73.
21. Siegel NJ, Brown RS. Peritoneal clearance of ammonia and creatinine in a neonate. J Pediatr 1973;82:1044-6.
22. Chen CY, Chen YC, Fang JT, Huang CC. Continuous arteriovenous hemodiafiltration in the acute treatment of hyperammonemia due to ornithine transcarbamylase deficiency. Ren Fail 2000;22:823-36.
23. Picca S, Dionisi-Vici C, Abeni D, Pastore A, Rizzo C, Orzalesi M, et al. Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr Nephrol 2001;16:862-7.
24. Sperl W, Geiger R, Maurer H, Guggenbichler JP. Continuous arteriovenous haemofiltration in hyperammonaemia of newborn babies. Lancet 1990;336:1192-3.
25. Sperl W, Geiger R, Maurer H, Murr C, Schmoigl C, Steichen-Gersdorf E, et al. Continuous arteriovenous haemofiltration in a neonate with hyperammonaemic coma due to citrullinaemia. J Inherit Metab Dis 1992;15:158-9.
26. Schaefer F, Straube E, Oh J, Mehls O, Mayatepek E. Dialysis in neonates with inborn errors of metabolism. Pediatr Nephrol 1999;14:910-8.
27. Wong KY, Wong SN, Lam SY, Tam S, Tsoi NS. Ammonia clearance by peritoneal dialysis and continuous arteriovenous hemodiafiltration. Pediatr Nephrol 1998;12:589-91.
28. Sadowski RH, Harmon WE, Jabs K. Acute hemodialysis of infants weighing less than five kilograms. Kidney Int 1994;45:903-6.
29. Wiegand C, Thompson T, Bock GH, Mathis RK, Kjellstrand CM, Mauer SM. The management of life-threatening hyperammonemia: a comparison of several therapeutic modalities. J Pediatr 1980;96:142-4.
30. Donn SM, Swartz RD, Thoene JG. Comparison of exchange transfusion, peritoneal dialysis, and hemodialysis for the treatment of hyperammonemia in an anuric newborn infant. J Pediatr 1979;95:67-70.
31. Summar M, Pietsch J, Deshpande J, Schulman G. Effective hemodialysis and hemofiltration driven by an extracorporeal membrane oxygenation pump in infants with hyperammonemia. J Pediatr 1996;128:379-82.
32. Navarro JF, Mora C, Leon C, Martin-Del Rio R, Macia ML, Gallego E, et al. Amino acid losses during hemodialysis with polyacrylonitrile membranes: effect of intradialytic amino acid supplementation on plasma amino acid concentrations and nutritional variables in nondiabetic patients. Am J Clin Nutr 2000;71:765-73.
33. Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 2000;28:1161-5.
34. Zimmerman L, Jörnavall H, Bergström J. Phenylacetylglutamine and hippuric acid in uremic and healthy subjects. Nephron 1990,55:265-71.